Published in J Urol on July 01, 1984
CD10 expression in urothelial carcinoma of the bladder. Diagn Pathol (2009) 1.09
Current status of intravesical chemotherapy trials in the EORTC Urological Group. An overview. Cancer Chemother Pharmacol (1987) 0.76
Comparison of 30 mg and 40 mg of mitomycin C intravesical instillation in Korean superficial bladder cancer patients: prospective, randomized study. Cancer Res Treat (2005) 0.75
Emerging intravesical therapies for management of nonmuscle invasive bladder cancer. Open Access J Urol (2010) 0.75
Biomarkers for early detection and optimized treatment for transitional cell carcinoma. Rev Urol (2001) 0.75
Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol (2001) 6.30
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res (1985) 4.39
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology (1996) 3.81
Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol (1999) 3.36
Non-alcoholic duct destructive chronic pancreatitis. Gut (1997) 2.79
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch (2001) 2.73
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer (1991) 2.52
Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch (2004) 2.44
Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia (1995) 2.19
Intraductal mucin-hypersecreting neoplasms of the pancreas. A clinicopathologic study of eight patients. Gastroenterology (1991) 2.14
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07
Solid-pseudopapillary tumor of the pancreas: its origin revisited. Virchows Arch (2000) 1.98
Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch (1995) 1.91
Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia (1987) 1.85
WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis (2007) 1.76
Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut (1996) 1.74
Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg (2000) 1.72
Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol (2001) 1.69
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci U S A (2000) 1.64
Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy (2010) 1.60
Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology (1998) 1.60
Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc Natl Acad Sci U S A (2009) 1.60
Pancreatic endocrine tumors. Hum Pathol (1982) 1.55
Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest (1996) 1.55
Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch (1994) 1.54
Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases. Histopathology (1983) 1.54
Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol (1994) 1.51
The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol (2001) 1.48
Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer (1989) 1.48
Idiosyncratic drug allergic phenprocoumon-induced hepatitis with subacute liver failure initially misdiagnosed as autoimmune hepatitis. Scand J Gastroenterol (2001) 1.47
The epidermal growth factor receptor in human pancreatic cancer. J Pathol (1992) 1.47
Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res (2001) 1.46
DNA ploidy and cell-cycle analysis in pancreatic and ampullary carcinoma: flow cytometric study of formalin-fixed paraffin-embedded tissue. Virchows Arch A Pathol Anat Histopathol (1990) 1.43
Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol (1993) 1.39
Transition zone cancers undermine the predictive accuracy of Partin table stage predictions. J Urol (2005) 1.39
Pseudotuberculous pyelonephritis associated with nephrolithiasis. Am J Surg Pathol (1992) 1.38
Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology (2008) 1.35
Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology (1992) 1.33
Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest (1986) 1.32
[Penetration of methylmethacrylate-monomer in blood circulation following hip joint prosthesis surgery in man]. Chirurg (1974) 1.30
The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer (1999) 1.29
Immunocytochemistry of paragangliomas--value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology (1991) 1.28
Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology (2004) 1.28
Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor. Cancer (1987) 1.27
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene (2006) 1.27
The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol (2000) 1.26
Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol (1989) 1.24
Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin. J Pathol (1998) 1.24
Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch (1999) 1.22
Transmural, haemorrhagic myocardial infarction after intracoronary streptokinase. Clinical, angiographic, and necropsy findings. Br Heart J (1982) 1.22
The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol (2002) 1.21
Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch A Pathol Anat Histol (1980) 1.21
Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol (1991) 1.21
Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity. Virchows Arch A Pathol Anat Histol (1977) 1.20
Solitary fibrous tumour of the pancreas: a new member of the small group of mesenchymal pancreatic tumours. Virchows Arch (1999) 1.20
Suicidal acts by children and adolescents. A follow-up study. Acta Psychiatr Scand Suppl (1972) 1.19
In-vivo confocal real-time mini-microscopy in animal models of human inflammatory and neoplastic diseases. Endoscopy (2007) 1.17
Human acute pancreatitis: its pathogenesis in the light of immunocytochemical and ultrastructural findings in acinar cells. Virchows Arch A Pathol Anat Histopathol (1986) 1.17
Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas. Diabetes (1994) 1.15
Cysts in left atrial myxomas identified by transesophageal cross-sectional echocardiography. Am J Cardiol (1983) 1.15
Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy. J Urol (1999) 1.14
Unenhanced helical computed tomography vs intravenous urography in patients with acute flank pain: accuracy and economic impact in a randomized prospective trial. Eur Radiol (2003) 1.14
A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol (2001) 1.13
Allelotype of pancreatic acinar cell carcinoma. Int J Cancer (2000) 1.11
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Br J Cancer (2004) 1.11
Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients. Cancer (1986) 1.11
Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas. Pancreas (1996) 1.11
Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Cancer Care (Engl) (2010) 1.10
Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumours. J Pathol (1997) 1.10
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology (2016) 1.09
Solid and cystic acinar cell tumour of the pancreas. A tumour in young women with favourable prognosis. Virchows Arch A Pathol Anat Histol (1981) 1.08
The erbB-3 gene in human pancreatic cancer. J Pathol (1992) 1.07
Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53. Cancer (2000) 1.07
6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. J Clin Endocrinol Metab (2010) 1.07
Beta-cell growth in adolescent and adult rats treated with streptozotocin during the neonatal period. Diabetologia (1996) 1.06
The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch (1998) 1.06
Male youths. A sociopsychiatric study of a total annual population of Swedish adolescent boys. Acta Psychiatr Scand Suppl (1976) 1.06
Endocrine tumors of the gut and pancreas tumor biology and classification. Neuroendocrinology (2004) 1.05
Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1. Oncogene (2007) 1.04
Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy. J Urol (1997) 1.04
Stage migration in clinically localized prostate cancer. Eur Urol (2000) 1.04
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol (1999) 1.03
Suicidal attempts made by pregnant women under 21 years. Acta Paedopsychiatr (1965) 1.03
Testis-specific beta 2 tubulins are identical in Drosophila melanogaster and D. hydei but differ from the ubiquitous beta 1 tubulin. Chromosoma (1987) 1.03
Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer (1991) 1.02
Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol (1989) 1.02
[Mesenchymal tumors of the pancreas. Surprising, but not uncommon]. Pathologe (2005) 1.02
Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology (1985) 1.01
Cytologic diagnosis of acinic-cell carcinoma of salivary glands. Diagn Cytopathol (1997) 1.00
Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy. Immunocytochemical analysis of tumors of 155 patients. Cancer (1983) 0.99
Cytologic diagnosis of adenoid cystic carcinoma of salivary glands. Diagn Cytopathol (1999) 0.99
Urological findings in patients with neurosurgically treated tethered spinal cord. J Urol (1993) 0.99
[Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications]. Urologe A (2003) 0.98